Overview

Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The stress response to surgery compromises a series of humoral, metabolic, or cellular reactions. Cardiac surgery with use of cardiopulmonary bypass (CPB) is a major activator of the systemic inflammatory response (SIRS). Inflammation, resulting in neutrophil activation, plays a central role in the production of reactive oxygen species (ROS). Inflammatory and oxidative reactions may play a role in the more frequent observation of postoperative ventricular dysfunction in patients with cyanotic congenital heart disease (CHD) undergoing surgery. The aim of this study is to compare the anti-inflammatory and anti-oxidative effects of propofol and sevoflurane in children with cyanotic CHD undergoing open heart surgery with CPB.
Phase:
Phase 4
Details
Lead Sponsor:
Cukurova University
Treatments:
Anesthetics
Propofol
Sevoflurane